USFDA issues OAI status to Sun Pharmaceutical’s Baska facility

18 Dec 2025 Evaluate

U.S. Food and Drug Administration (USFDA) has conducted an inspection at Sun Pharmaceutical Industries’ Baska facility from September 08, 2025 to September 19, 2025. The US FDA has subsequently determined that the inspection classification status of this facility is Official Action Indicated (OAI).

The company continues to manufacture and supply approved products from the facility to the US market. The company will work with the regulator to achieve fully compliant status.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Sun Pharma Inds. Share Price

1745.35 -49.75 (-2.77%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×